ZFIN Image: Cui et al., 2023, FIGURE 5

Image

Figure Caption

FIGURE 5

In vitro cytotoxicity of amino acid modified OCMC-g-Suc-β-CD nanohydrogels 1-6 carrying anticancer drugs against A549 cells after incubation for 48 h. Nanohydrogels 1: L-His-OCMC-g-Suc-β-CD carrying Lapatinib; nanohydrogels 2: L-His-OCMC-g-Suc-β-CD carrying ginsenoside Rg1; nanohydrogels 3: L-Arg-OCMC-g-Suc-β-CD carrying lapatinib; nanohydrogels 4: L-Arg-OCMC-g-Suc-β-CD carrying ginsenoside Rg1; nanohydrogels 5: L-His-OCMC-g-Suc-β-CD carrying lapatinib and ginsenoside Rg1; nanohydrogels 6: L-Arg-OCMC-g-Suc-β-CD carrying lapatinib and ginsenoside Rg1. The experiments were repeated 3 times, each with n = 3 per group. The data were presented as mean ± SEM and analyzed by one-way ANOVA followed by Dunett’s test using Graph Pad Prism 6.01 software. *p < 0.05, **p < 0.01, ***p < 0.001 VS. 0 µg/mL for each group.

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Front Pharmacol